Based on the next-generation sequencing technology, combined with Unique Molecular Identifier (UMI) technology and ctDNA-Monitor cloning analysis technology, the patient's tumor molecular burden and tumor molecular cloning are calculated, thereby realizing personalized efficacy monitoring.

[Product Advantages] UMI technology and ultra-high depth sequencing, ctDNA-Monitor cloning analysis technology